Avanos Medical, Inc. Stock price

Equities

AVNS

US05350V1061

Medical Equipment, Supplies & Distribution

Market Closed - Nyse 04:00:01 2024-02-23 pm EST 5-day change 1st Jan Change
19.69 USD +0.51% Intraday chart for Avanos Medical, Inc. +2.61% -12.22%
Sales 2024 * 691M Sales 2025 * 728M Capitalization 850M
Net income 2024 * - Net income 2025 * - EV / Sales 2024 * 1.23 x
Net cash position 2024 * - Net cash position 2025 * - EV / Sales 2025 * 1.17 x
P/E ratio 2024 *
-
P/E ratio 2025 *
-
Employees 3,771
Yield 2024 *
-
Yield 2025 *
-
Free-Float 91.45%
More Fundamentals * Assessed data
Dynamic Chart
1 day+0.51%
1 week+2.61%
Current month+2.61%
1 month+1.13%
3 months-7.73%
6 months-10.21%
Current year-12.22%
More quotes
1 week
18.05
Extreme 18.05
19.88
1 month
18.05
Extreme 18.05
19.93
Current year
17.39
Extreme 17.39
23.09
1 year
17.24
Extreme 17.235
31.31
3 years
17.24
Extreme 17.235
48.88
5 years
17.24
Extreme 17.235
53.61
10 years
17.24
Extreme 17.235
72.96
More quotes
Managers TitleAgeSince
Chief Executive Officer 58 17-06-25
Director of Finance/CFO 51 19-12-31
Compliance Officer - 20-09-14
Members of the board TitleAgeSince
Chairman 66 14-10-30
Director/Board Member 66 14-10-30
Director/Board Member 65 14-09-30
More insiders
Date Price Change Volume
24-02-23 19.69 +0.51% 177,555
24-02-22 19.59 +0.41% 252,999
24-02-21 19.51 +0.05% 277,577
24-02-20 19.5 +1.62% 395,341
24-02-16 19.19 -2.59% 384,305

Delayed Quote Nyse, February 23, 2024 at 04:00 pm EST

More quotes
Avanos Medical, Inc. is a medical device company, which is focused on delivering solutions. The Company offers healthcare needs, such as providing nutrition to patients from hospital to home and reducing the use of opioids while helping patients move from surgery to recovery. The Company conducts its business in one segment that provides its medical device products to healthcare providers and patients globally with manufacturing facilities in the United States and Mexico. Its digestive health products include MIC-KEY enteral feeding tubes, Corpak patient feeding solutions and NeoMed neonatal and pediatric feeding solutions. Its acute pain products include ON-Q and ambIT surgical pain pumps and Game Ready cold and compression therapy systems. The Company's interventional pain solutions include COOLIEF pain therapy and OrthogenRxs knee osteoarthritis pain relief injection products.
Related indices
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
B-
More Ratings
Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
3
Last Close Price
19.69 USD
Average target price
23.5 USD
Spread / Average Target
+19.35%
Consensus
  1. Stock
  2. Equities
  3. Stock Avanos Medical, Inc. - Nyse
+229% on MICROSOFT CORPORATION since our purchase on January 11, 2019
Replicate our performance
fermer